Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Cognition in Parkinson's Disease
NCT01723228Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Nov 2012
- Primary completion
- Jan 2015
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by Teva Pharmaceutical Industries Ltd.. Started Nov 2012; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01723228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01723228.